HIMP.... you are asking the correct questions. imo!!! Below is the original wording of the press release about the contract with the RBL:
"Under terms of the agreement, scientific research partners at the RBL plan to evaluate Brilacidin’s potential antiviral and anti-inflammatory properties in the context of viral infections, including inhibition of SARS-CoV-2, the virus responsible for COVID-19. Mechanism of action studies of Brilacidin, along with assessing possible synergistic effects with other antivirals, are also planned. It is anticipated these tests might be completed within several weeks of the RBL’s receipt of Brilacidin."
This is the one i am most interested in knowing about:
"along with assessing possible synergistic effects with other antivirals, are also planned."
Did they test it with Hydroxychloroquine???